Mycobacterium avium complex pulmonary disease in patients with pre-existing lung disease

Research output: Contribution to journalReview article

67 Citations (Scopus)

Abstract

Patients with MAC-PD and pre-existing lung disease are a distinct group from the more common and recently recognized group of predominantly middle- to older-aged women without pre-existing lung disease. Those with pre-existing disease are expected to have more sputum positivity and slower conversion of sputum with treatment, and they may require combined medical treatment with surgical resection for optimal results. Attention to bronchial hygiene, avoidance of unnecessary use of macrolides, and treatment of underlying esophageal and lung disease can result in marked symptomatic improvement in many cases. Appropriate consideration must be given to mycobacterial antibiotic treatment, and awareness must be maintained for other processes such as bronchogenic cancer in select groups of high-risk patients.

Original languageEnglish (US)
Pages (from-to)643-653
Number of pages11
JournalClinics in Chest Medicine
Volume23
Issue number3
DOIs
StatePublished - Sep 2002

Fingerprint

Mycobacterium avium Complex
Preexisting Condition Coverage
Lung Diseases
Sputum
Esophageal Diseases
Macrolides
Therapeutics
Hygiene
Anti-Bacterial Agents
Neoplasms

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Mycobacterium avium complex pulmonary disease in patients with pre-existing lung disease. / Aksamit, Timothy.

In: Clinics in Chest Medicine, Vol. 23, No. 3, 09.2002, p. 643-653.

Research output: Contribution to journalReview article

@article{120104100f99490eaf8e60d40637f0fc,
title = "Mycobacterium avium complex pulmonary disease in patients with pre-existing lung disease",
abstract = "Patients with MAC-PD and pre-existing lung disease are a distinct group from the more common and recently recognized group of predominantly middle- to older-aged women without pre-existing lung disease. Those with pre-existing disease are expected to have more sputum positivity and slower conversion of sputum with treatment, and they may require combined medical treatment with surgical resection for optimal results. Attention to bronchial hygiene, avoidance of unnecessary use of macrolides, and treatment of underlying esophageal and lung disease can result in marked symptomatic improvement in many cases. Appropriate consideration must be given to mycobacterial antibiotic treatment, and awareness must be maintained for other processes such as bronchogenic cancer in select groups of high-risk patients.",
author = "Timothy Aksamit",
year = "2002",
month = "9",
doi = "10.1016/S0272-5231(02)00022-9",
language = "English (US)",
volume = "23",
pages = "643--653",
journal = "Clinics in Chest Medicine",
issn = "0272-5231",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Mycobacterium avium complex pulmonary disease in patients with pre-existing lung disease

AU - Aksamit, Timothy

PY - 2002/9

Y1 - 2002/9

N2 - Patients with MAC-PD and pre-existing lung disease are a distinct group from the more common and recently recognized group of predominantly middle- to older-aged women without pre-existing lung disease. Those with pre-existing disease are expected to have more sputum positivity and slower conversion of sputum with treatment, and they may require combined medical treatment with surgical resection for optimal results. Attention to bronchial hygiene, avoidance of unnecessary use of macrolides, and treatment of underlying esophageal and lung disease can result in marked symptomatic improvement in many cases. Appropriate consideration must be given to mycobacterial antibiotic treatment, and awareness must be maintained for other processes such as bronchogenic cancer in select groups of high-risk patients.

AB - Patients with MAC-PD and pre-existing lung disease are a distinct group from the more common and recently recognized group of predominantly middle- to older-aged women without pre-existing lung disease. Those with pre-existing disease are expected to have more sputum positivity and slower conversion of sputum with treatment, and they may require combined medical treatment with surgical resection for optimal results. Attention to bronchial hygiene, avoidance of unnecessary use of macrolides, and treatment of underlying esophageal and lung disease can result in marked symptomatic improvement in many cases. Appropriate consideration must be given to mycobacterial antibiotic treatment, and awareness must be maintained for other processes such as bronchogenic cancer in select groups of high-risk patients.

UR - http://www.scopus.com/inward/record.url?scp=0036739581&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036739581&partnerID=8YFLogxK

U2 - 10.1016/S0272-5231(02)00022-9

DO - 10.1016/S0272-5231(02)00022-9

M3 - Review article

C2 - 12371000

AN - SCOPUS:0036739581

VL - 23

SP - 643

EP - 653

JO - Clinics in Chest Medicine

JF - Clinics in Chest Medicine

SN - 0272-5231

IS - 3

ER -